SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-23-068924
Filing Date
2023-12-08
Accepted
2023-12-08 08:15:04
Documents
2
Period of Report
2023-12-06

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1535
2 EX-24 tcrx-ex24.htm EX-24 12596
  Complete submission text file 0000950170-23-068924.txt   15483
Mailing Address 880 WINTER STREET WALTHAM MA 02451
Business Address 880 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Issuer) CIK: 0001783328 (see all company filings)

IRS No.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O X4 PHARMACEUTICALS INC. 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address
Woods Keith (Reporting) CIK: 0001996804 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40603 | Film No.: 231473968